BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci 2020;253:117723. [PMID: 32360126 DOI: 10.1016/j.lfs.2020.117723] [Cited by in Crossref: 127] [Cited by in F6Publishing: 115] [Article Influence: 63.5] [Reference Citation Analysis]
Number Citing Articles
1 Ogunjimi M, Haiduc AA, Harky A. Congenital heart disease and incremental risks of COVID-19. J Card Surg 2021;36:433-5. [PMID: 33331065 DOI: 10.1111/jocs.15246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ernzen K, Trask AJ, Peeples ME, Garg V, Zhao MT. Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System. Stem Cell Rev Rep 2021. [PMID: 34365591 DOI: 10.1007/s12015-021-10229-4] [Reference Citation Analysis]
3 Buicu AL, Cernea S, Benedek I, Buicu CF, Benedek T. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity. J Clin Med 2021;10:1545. [PMID: 33916917 DOI: 10.3390/jcm10081545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lozano Gómez H, Pascual Bielsa A, Arche Banzo MJ. Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection. Med Clin (Engl Ed) 2020;155:463-4. [PMID: 33163627 DOI: 10.1016/j.medcle.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ziegler O, Sriram N, Gelev V, Radeva D, Todorov K, Feng J, Sellke FW, Robson SC, Hiromura M, Alexandrov BS, Usheva A. The cardiac molecular setting of metabolic syndrome in pigs reveals disease susceptibility and suggests mechanisms that exacerbate COVID-19 outcomes in patients. Sci Rep 2021;11:19752. [PMID: 34611227 DOI: 10.1038/s41598-021-99143-w] [Reference Citation Analysis]
6 Kaur R, Singh S, Singh TG, Sood P, Robert J. Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination. Inflammopharmacology 2022. [PMID: 34981320 DOI: 10.1007/s10787-021-00904-w] [Reference Citation Analysis]
7 Grosse C, Grosse A, Salzer HJF, Dünser MW, Motz R, Langer R. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc Pathol 2020;49:107263. [PMID: 32784110 DOI: 10.1016/j.carpath.2020.107263] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
8 Rezabakhsh A, Sadat-Ebrahimi SR, Ala A, Nabavi SM, Banach M, Ghaffari S. A close-up view of dynamic biomarkers in the setting of COVID-19: Striking focus on cardiovascular system. J Cell Mol Med 2021. [PMID: 34894069 DOI: 10.1111/jcmm.17122] [Reference Citation Analysis]
9 Caiado LDC, Azevedo NC, Azevedo RRC, Caiado BR. Cardiac involvement in patients recovered from COVID-19 identified using left ventricular longitudinal strain. J Echocardiogr 2021. [PMID: 34648149 DOI: 10.1007/s12574-021-00555-4] [Reference Citation Analysis]
10 Johnson JE, McGuone D, Xu ML, Jane-Wit D, Mitchell RN, Libby P, Pober JS. Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis: Correlation with Neutrophil but Not Endothelial Activation. Am J Pathol 2021:S0002-9440(21)00429-6. [PMID: 34599881 DOI: 10.1016/j.ajpath.2021.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Haddadin FI, Mahdawi TE, Hattar L, Beydoun H, Fram F, Homoud M. A case of complete heart block in a COVID-19 infected patient. J Cardiol Cases 2021;23:27-30. [PMID: 32904735 DOI: 10.1016/j.jccase.2020.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782-792. [PMID: 32687793 DOI: 10.1016/s2213-8587(20)30238-2] [Cited by in Crossref: 263] [Cited by in F6Publishing: 170] [Article Influence: 131.5] [Reference Citation Analysis]
13 Shah P, Doshi R, Chenna A, Owens R, Cobb A, Ivey H, Newton S, Mccarley K. Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients.Am J Cardiol. 2020;135:150-153. [PMID: 32861733 DOI: 10.1016/j.amjcard.2020.08.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
14 Liu W, Liu Z, Li YC. COVID-19-related myocarditis and cholinergic anti-inflammatory pathways. Hellenic J Cardiol 2021;62:265-9. [PMID: 33301863 DOI: 10.1016/j.hjc.2020.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Tanwar V, Adelstein JM, Wold LE. Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019. Cardiovasc Res 2021;117:85-95. [PMID: 33084879 DOI: 10.1093/cvr/cvaa293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
16 Puthiyedath R, Kataria S, Payyappallimana U, Mangalath P, Nampoothiri V, Sharma P, Singh MK, Kumar K, Trehan N. Ayurvedic clinical profile of COVID-19 - A preliminary report. J Ayurveda Integr Med 2020:S0975-9476(20)30039-5. [PMID: 32624376 DOI: 10.1016/j.jaim.2020.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
17 Dembinski R. Prone Positioning in Coronavirus Disease 2019: Just Do It! Crit Care Med 2021;49:1186-8. [PMID: 34135274 DOI: 10.1097/CCM.0000000000004979] [Reference Citation Analysis]
18 Ahmad F, Gandre P, Nguekam J, Wall A, Ong S, Karuppamakkantakath AN, Tasopoulos K, Sadiq MA, Kasim S, Cuesta JM. Complete Heart Block as a Clinical Feature in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series of Three Cases. Case Rep Crit Care 2021;2021:9955466. [PMID: 34422417 DOI: 10.1155/2021/9955466] [Reference Citation Analysis]
19 Cui N, Yan R, Qin C, Zhao J. Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study. Front Cell Infect Microbiol 2020;10:595333. [PMID: 33365277 DOI: 10.3389/fcimb.2020.595333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, Shafaati M, Abdoli A. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol 2021;101:108232. [PMID: 34673335 DOI: 10.1016/j.intimp.2021.108232] [Reference Citation Analysis]
21 Liao B, Chen Z, Zheng P, Li L, Zhuo J, Li F, Li S, Chen D, Wen C, Cai W, Wu S, Tang Y, Duan L, Wei P, Chen F, Yuan J, Yang J, Feng J, Zhao J, Zhao J, Sun B, Zhu A, Li Y, Tang X. Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients. Front Immunol 2021;12:724763. [PMID: 34489978 DOI: 10.3389/fimmu.2021.724763] [Reference Citation Analysis]
22 Dherange P, Lang J, Qian P, Oberfeld B, Sauer WH, Koplan B, Tedrow U. Arrhythmias and COVID-19: A Review. JACC Clin Electrophysiol 2020;6:1193-204. [PMID: 32972561 DOI: 10.1016/j.jacep.2020.08.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
23 Cao J, Zheng Y, Luo Z, Mei Z, Yao Y, Liu Z, Liang C, Yang H, Song Y, Yu K, Gao Y, Zhu C, Huang Z, Qian J, Ge J. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease. Theranostics 2020;10:9663-73. [PMID: 32863952 DOI: 10.7150/thno.47980] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
24 Amere Subbarao S. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting. Inflammopharmacology 2021;29:343-66. [PMID: 33723711 DOI: 10.1007/s10787-021-00796-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Valchanov K, Krishnan U, Hoole SP, Davies WR, Pettit S, Jones N, Parmar J, Catarino P, Osman M, Berman M. COVID-19 patient with coronary thrombosis supported with ECMO and Impella 5.0 ventricular assist device: a case report. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33442588 DOI: 10.1093/ehjcr/ytaa342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Bansal A, Kumar A, Patel D, Puri R, Kalra A, Kapadia SR, Reed GW. Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19). Am J Cardiol 2021;141:140-6. [PMID: 33217345 DOI: 10.1016/j.amjcard.2020.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
27 Sazgarnejad S, Yazdanpanah N, Rezaei N. Anti-inflammatory effects of GLP-1 in patients with COVID-19. Expert Rev Anti Infect Ther 2021;:1-9. [PMID: 34348067 DOI: 10.1080/14787210.2021.1964955] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Babapoor-Farrokhran S, Batnyam U, Wiener PC, Kanjanahattakij N, Khraisha O, Amanullah A, Mainigi SK. Atrioventricular and Sinus Node Dysfunction in Stable COVID-19 Patients. SN Compr Clin Med 2020;:1-4. [PMID: 32901230 DOI: 10.1007/s42399-020-00497-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
29 Bonavita AG. Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis. Med Hypotheses 2020;145:110352. [PMID: 33129009 DOI: 10.1016/j.mehy.2020.110352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Laganà N, Cei M, Evangelista I, Cerutti S, Colombo A, Conte L, Mormina E, Rotiroti G, Versace AG, Porta C, Capra R, Vacirca V, Vitale J, Mazzone A, Mumoli N. Suspected myocarditis in patients with COVID-19: A multicenter case series. Medicine (Baltimore) 2021;100:e24552. [PMID: 33663062 DOI: 10.1097/MD.0000000000024552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Rios CI, Cassatt DR, Hollingsworth BA, Satyamitra MM, Tadesse YS, Taliaferro LP, Winters TA, DiCarlo AL. Commonalities Between COVID-19 and Radiation Injury. Radiat Res 2021;195:1-24. [PMID: 33064832 DOI: 10.1667/RADE-20-00188.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
32 Chong PY, Iqbal J, Yeong J, Aw TC, Chan KS, Chui P. Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies. Front Mol Biosci 2021;8:658932. [PMID: 34765640 DOI: 10.3389/fmolb.2021.658932] [Reference Citation Analysis]
33 Goldstein DS. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res 2020;30:299-315. [PMID: 32700055 DOI: 10.1007/s10286-020-00714-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
34 Mehrabadi ME, Hemmati R, Tashakor A, Homaei A, Yousefzadeh M, Hemati K, Hosseinkhani S. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity. Biomed Pharmacother 2021;137:111363. [PMID: 33582450 DOI: 10.1016/j.biopha.2021.111363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kuluöztürk M, İn E, Telo S, Karabulut E, Geçkil AA. Efficacy of copeptin in distinguishing COVID-19 pneumonia from community-acquired pneumonia. J Med Virol 2021;93:3113-21. [PMID: 33570194 DOI: 10.1002/jmv.26870] [Reference Citation Analysis]
36 Fiore G, Sanvito F, Fragasso G, Spoladore R. Case report of cardiogenic shock in COVID-19 myocarditis: peculiarities on diagnosis, histology, and treatment. Eur Heart J Case Rep 2021;5:ytab357. [PMID: 34651099 DOI: 10.1093/ehjcr/ytab357] [Reference Citation Analysis]
37 Ashraf H, Soleimani A, Kazemi saeid A, Sadat Naseri A, Majidi F, Peirovi N, Karbalai Saleh S. Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review. World J Meta-Anal 2021; 9(4): 342-352 [DOI: 10.13105/wjma.v9.i4.342] [Reference Citation Analysis]
38 Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020;14:1043-51. [PMID: 32640416 DOI: 10.1016/j.dsx.2020.06.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
39 Yoo J, Grewal P, Hotelling J, Papamanoli A, Cao K, Dhaliwal S, Jacob R, Mojahedi A, Bloom ME, Marcos LA, Skopicki HA, Kalogeropoulos AP. Admission NT-proBNP and outcomes in patients without history of heart failure hospitalized with COVID-19. ESC Heart Fail 2021. [PMID: 34346182 DOI: 10.1002/ehf2.13548] [Reference Citation Analysis]
40 Yu JS, Pan NN, Chen RD, Zeng LC, Yang HK, Li H. Cardiac Biomarker Levels and Their Prognostic Values in COVID-19 Patients With or Without Concomitant Cardiac Disease. Front Cardiovasc Med 2020;7:599096. [PMID: 33553255 DOI: 10.3389/fcvm.2020.599096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
41 Rao GSNK, Gowthami B, Naveen NR, Samudrala PK. An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19. Curr Res Pharmacol Drug Discov 2021;2:100063. [PMID: 34870158 DOI: 10.1016/j.crphar.2021.100063] [Reference Citation Analysis]
42 He DD, Zhang XK, Zhu XY, Huang FF, Wang Z, Tu JC. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction. Comput Biol Med 2021;131:104293. [PMID: 33662681 DOI: 10.1016/j.compbiomed.2021.104293] [Reference Citation Analysis]
43 Li XT, Zhang MW, Zhang ZZ, Cao YD, Liu XY, Miao R, Xu Y, Song XF, Song JW, Liu Y, Xu YL, Li J, Dong Y, Zhong JC. Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19. Int J Cardiol 2021;336:123-9. [PMID: 34000358 DOI: 10.1016/j.ijcard.2021.05.029] [Reference Citation Analysis]
44 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Reference Citation Analysis]
45 Qureshi NK, Bansal SK. Autoimmune Thyroid Disease and Psoriasis Vulgaris after COVID-19 in a Male Teenager. Case Rep Pediatr 2021;2021:7584729. [PMID: 34354847 DOI: 10.1155/2021/7584729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Dos Anjos F, Simões JLB, Assmann CE, Carvalho FB, Bagatini MD. Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2. J Immunol Res 2020;2020:8632048. [PMID: 33299899 DOI: 10.1155/2020/8632048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
47 Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, Schuepbach RA, Moch H, Varga Z. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine 2021;63:103182. [PMID: 33422990 DOI: 10.1016/j.ebiom.2020.103182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
48 Nikoo MH, Mozaffari R, Hatamnejad MR, Bazrafshan M, Kasaei M, Bazrafshan H. Systolic dysfunction and complete heart block as complications of fulminant myocarditis in a recovered COVID-19 patient. J Cardiol Cases 2021;24:177-81. [PMID: 33897917 DOI: 10.1016/j.jccase.2021.03.009] [Reference Citation Analysis]
49 Goerlich E, Gilotra NA, Minhas AS, Bavaro N, Hays AG, Cingolani OH. Prominent Longitudinal Strain Reduction of Basal Left Ventricular Segments in Patients With Coronavirus Disease-19. J Card Fail 2021;27:100-4. [PMID: 32991982 DOI: 10.1016/j.cardfail.2020.09.469] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
50 Shafiabadi Hassani N, Talakoob H, Karim H, Mozafari Bazargany MH, Rastad H. Cardiac Magnetic Resonance Imaging Findings in 2954 COVID-19 Adult Survivors: A Comprehensive Systematic Review. J Magn Reson Imaging 2021. [PMID: 34309139 DOI: 10.1002/jmri.27852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Wang H, Li R, Zhou Z, Jiang H, Yan Z, Tao X, Li H, Xu L. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2021;23:14. [PMID: 33627143 DOI: 10.1186/s12968-021-00710-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
52 Babapoor-Farrokhran S, Rasekhi RT, Gill D, Babapoor S, Amanullah A. Arrhythmia in COVID-19. SN Compr Clin Med 2020;:1-6. [PMID: 32838188 DOI: 10.1007/s42399-020-00454-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
53 Yang Y, Xiao Z, Ye K, He X, Sun B, Qin Z, Yu J, Yao J, Wu Q, Bao Z, Zhao W. SARS-CoV-2: characteristics and current advances in research. Virol J 2020;17:117. [PMID: 32727485 DOI: 10.1186/s12985-020-01369-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
54 Lopes LR. Functional and tissue enrichment analyses suggest that SARS-CoV-2 infection affects host metabolism and catabolism mediated by interference on host proteins. Braz J Microbiol 2021;52:1151-9. [PMID: 33956332 DOI: 10.1007/s42770-021-00497-0] [Reference Citation Analysis]
55 Sheik Abdul N, Marnewick JL. Rooibos, a supportive role to play during the COVID-19 pandemic? J Funct Foods 2021;86:104684. [PMID: 34422116 DOI: 10.1016/j.jff.2021.104684] [Reference Citation Analysis]
56 Boerma EC, Bethlehem C, Stellingwerf F, de Lange F, Streng KW, Koetsier PM, Bootsma IT. Hemodynamic Characteristics of Mechanically Ventilated COVID-19 Patients: A Cohort Analysis. Crit Care Res Pract 2021;2021:8882753. [PMID: 33425387 DOI: 10.1155/2021/8882753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
57 Gu ZC, Zhang C, Kong LC, Shen L, Li Z, Ge H, Lin HW, Pu J. Incidence of myocardial injury in coronavirus disease 2019 (COVID-19): a pooled analysis of 7,679 patients from 53 studies. Cardiovasc Diagn Ther 2020;10:667-77. [PMID: 32968623 DOI: 10.21037/cdt-20-535] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
58 Alosaimi B, Naeem A, Hamed ME, Alkadi HS, Alanazi T, Al Rehily SS, Almutairi AZ, Zafar A. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J 2021;18:127. [PMID: 34127006 DOI: 10.1186/s12985-021-01594-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
59 Yang J, Chen T, Zhou Y. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes. Hereditas. 2021;158:4. [PMID: 33397514 DOI: 10.1186/s41065-020-00168-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
60 Guéant JL, Guéant-Rodriguez RM, Fromonot J, Oussalah A, Louis H, Chery C, Gette M, Gleye S, Callet J, Raso J, Blanchecotte F, Lacolley P, Guieu R, Regnault V. Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19. Allergy 2021;76:1846-58. [PMID: 33484168 DOI: 10.1111/all.14746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
61 Bernal-Torres W, Herrera-Escandón Á, Hurtado-Rivera M, Plata-Mosquera CA. COVID-19 fulminant myocarditis: a case report. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33089053 DOI: 10.1093/ehjcr/ytaa212] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
62 De Carvalho H, Leonard-Pons L, Segard J, Goffinet N, Javaudin F, Martinage A, Cattin G, Tiberghien S, Therasse D, Trotignon M, Arabucki F, Ribes S, Le Bastard Q, Montassier E. Electrocardiographic abnormalities in COVID-19 patients visiting the emergency department: a multicenter retrospective study. BMC Emerg Med 2021;21:141. [PMID: 34798827 DOI: 10.1186/s12873-021-00539-8] [Reference Citation Analysis]
63 Turshudzhyan A. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Induced Cardiovascular Syndrome: Etiology, Outcomes, and Management. Cureus 2020;12:e8543. [PMID: 32670680 DOI: 10.7759/cureus.8543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Shi L, Wang Y, Wang Y, Duan G, Yang H. Meta-Analysis of Relation of Creatine kinase-MB to Risk of Mortality in Coronavirus Disease 2019 Patients. Am J Cardiol 2020;130:163-5. [PMID: 32622501 DOI: 10.1016/j.amjcard.2020.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Aleksova A, Sinagra G, Beltrami AP, Pierri A, Ferro F, Janjusevic M, Gagno G. Biomarkers in the management of acute heart failure: state of the art and role in COVID-19 era. ESC Heart Fail 2021. [PMID: 34609075 DOI: 10.1002/ehf2.13595] [Reference Citation Analysis]
66 Kluge S, Janssens U, Welte T, Weber-Carstens S, Schälte G, Spinner CD, Malin JJ, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Böttiger BW, Weinmann-Menke J, Kersten A, Berlit P, Haase R, Marx G, Karagiannidis C. [S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19]. Pneumologie 2021;75:88-112. [PMID: 33450783 DOI: 10.1055/a-1334-1925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
67 Patiyal S, Kaur D, Kaur H, Sharma N, Dhall A, Sahai S, Agrawal P, Maryam L, Arora C, Raghava GP. A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2020;39:204-16. [DOI: 10.1089/mab.2020.0035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
68 Hartmann C, Miggiolaro AFRDS, Motta JDS, Baena Carstens L, Busatta Vaz De Paula C, Fagundes Grobe S, Hermann de Souza Nunes L, Lenci Marques G, Libby P, Zytynski Moura L, de Noronha L, Pellegrino Baena C. The Pathogenesis of COVID-19 Myocardial Injury: An Immunohistochemical Study of Postmortem Biopsies. Front Immunol 2021;12:748417. [PMID: 34804033 DOI: 10.3389/fimmu.2021.748417] [Reference Citation Analysis]
69 Fazal F, Gupta N, Khot W, Ray Y. Collateral damage due to COVID-19. Trop Doct 2021;51:126-7. [PMID: 32715939 DOI: 10.1177/0049475520942387] [Reference Citation Analysis]
70 Li B, Yu J, Liu P, Zeng T, Zeng X. Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway. Ann Transl Med 2021;9:1435. [PMID: 34733987 DOI: 10.21037/atm-21-4080] [Reference Citation Analysis]
71 Hadzibegovic S, Lena A, Churchill TW, Ho JE, Potthoff S, Denecke C, Rösnick L, Heim KM, Kleinschmidt M, Sander LE, Witzenrath M, Suttorp N, Krannich A, Porthun J, Friede T, Butler J, Wilkenshoff U, Pieske B, Landmesser U, Anker SD, Lewis GD, Tschöpe C, Anker MS. Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail 2021. [PMID: 33932255 DOI: 10.1002/ejhf.2210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Raza HA, Tariq J, Agarwal V, Gupta L. COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases. Rheumatol Int 2021;41:257-73. [PMID: 33386447 DOI: 10.1007/s00296-020-04759-2] [Reference Citation Analysis]
73 Sui J, Noubouossie DF, Gandotra S, Cao L. Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients. Front Cell Infect Microbiol 2021;11:734005. [PMID: 34414135 DOI: 10.3389/fcimb.2021.734005] [Reference Citation Analysis]
74 Li XL, Wu C, Xie JG, Zhang B, Kui X, Jia D, Liang CN, Zhou Q, Zhang Q, Gao Y, Zhou X, Hou G. Development and Validation of a Nomogram for Predicting the Disease Progression of Nonsevere Coronavirus Disease 2019. J Transl Int Med 2021;9:131-42. [PMID: 34497752 DOI: 10.2478/jtim-2021-0030] [Reference Citation Analysis]
75 Grzegorowska O, Lorkowski J. Possible Correlations between Atherosclerosis, Acute Coronary Syndromes and COVID-19. J Clin Med 2020;9:E3746. [PMID: 33233333 DOI: 10.3390/jcm9113746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
76 Golpour A, Patriki D, Hanson PJ, McManus B, Heidecker B. Epidemiological Impact of Myocarditis. J Clin Med 2021;10:603. [PMID: 33562759 DOI: 10.3390/jcm10040603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
77 Negreira-Caamaño M, Río JM, Águila-Gordo D, Mateo-Gómez C, Soto-Pérez M, Piqueras-Flores J. [Cardiovascular events after COVID-19 hospitalization: long-term follow-up]. Rev Esp Cardiol 2021. [PMID: 34334882 DOI: 10.1016/j.recesp.2021.07.009] [Reference Citation Analysis]
78 Jin S, Hu W. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes. Front Endocrinol (Lausanne) 2021;12:602735. [PMID: 33995267 DOI: 10.3389/fendo.2021.602735] [Reference Citation Analysis]
79 Atri L, Morgan M, Harrell S, AlJaroudi W, Berman AE. Role of cardiac magnetic resonance imaging in the diagnosis and management of COVID-19 related myocarditis: Clinical and imaging considerations. World J Radiol 2021; 13(9): 283-293 [PMID: 34630914 DOI: 10.4329/wjr.v13.i9.283] [Reference Citation Analysis]
80 Chaughtai S, Soomro R, Chaughtai K, Anwaar W, Chaughtai Z, Asif A, Hossain MA. Large Vessel Stroke Following Multiple Other Strokes and Cardiomyopathy in a Forty-Nine-Year-Old COVID-19 Patient. J Med Cases 2021;12:238-42. [PMID: 34429796 DOI: 10.14740/jmc3682] [Reference Citation Analysis]
81 Turski WA, Wnorowski A, Turski GN, Turski CA, Turski L. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives. Restor Neurol Neurosci 2020;38:343-54. [PMID: 32597823 DOI: 10.3233/RNN-201042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
82 Das SK. The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19). Indian J Clin Biochem 2020;:1-12. [PMID: 32837036 DOI: 10.1007/s12291-020-00919-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
83 Mizera L, Borst O. COVID-19 and the Incidence of Acute Myocardial Injury. Hamostaseologie 2021;41:356-64. [PMID: 34695852 DOI: 10.1055/a-1554-6416] [Reference Citation Analysis]
84 Mester A, Benedek I, Rat N, Tolescu C, Polexa SA, Benedek T. Imaging Cardiovascular Inflammation in the COVID-19 Era. Diagnostics (Basel) 2021;11:1114. [PMID: 34207266 DOI: 10.3390/diagnostics11061114] [Reference Citation Analysis]
85 Zhang Z, Waters R, Li Y. Pathogenesis of non-epithelial foot-and-mouth disease in neonatal animals. Vet Microbiol 2021;254:108961. [PMID: 33545638 DOI: 10.1016/j.vetmic.2020.108961] [Reference Citation Analysis]
86 Gervasi SF, Pengue L, Damato L, Monti R, Pradella S, Pirronti T, Bartoloni A, Epifani F, Saggese A, Cuccaro F, Bianco M, Zeppilli P, Palmieri V. Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection? Br J Sports Med 2021;55:54-61. [PMID: 33020140 DOI: 10.1136/bjsports-2020-102789] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
87 Sun B, Wang H, Lv J, Pei H, Bai Z. Predictors of Mortality in Hospitalized COVID-19 Patients Complicated With Hypotension and Hypoxemia: A Retrospective Cohort Study. Front Med (Lausanne) 2021;8:753035. [PMID: 34778315 DOI: 10.3389/fmed.2021.753035] [Reference Citation Analysis]
88 Ulloque-Badaracco JR, Hernandez-Bustamante EA, Herrera-Añazco P, Benites-Zapata VA. Prognostic value of apolipoproteins in COVID-19 patients: A systematic review and meta-analysis. Travel Med Infect Dis 2021;44:102200. [PMID: 34752921 DOI: 10.1016/j.tmaid.2021.102200] [Reference Citation Analysis]
89 Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
90 Mamishi S, Zeinaloo A, Haji Esmaeil Memar E, Khodabandeh M, Mirzaaghayan MR, Abdolsalehi MR, Eshaghi H, Gorji M, Ghamari A, Aghaei Moghadam E. Little Hearts Are Affected by COVID19: Importance of the Myocardial Systolic Evaluation. Front Pediatr 2021;9:697213. [PMID: 34557458 DOI: 10.3389/fped.2021.697213] [Reference Citation Analysis]
91 Liguori C, Farina D, Vaccher F, Ferrandino G, Bellini D, Carbone I. Myocarditis: imaging up to date. Radiol Med 2020;125:1124-34. [PMID: 33025305 DOI: 10.1007/s11547-020-01279-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Arumugam VA, Thangavelu S, Fathah Z, Ravindran P, Sanjeev AMA, Babu S, Meyyazhagan A, Yatoo MI, Sharun K, Tiwari R, Pandey MK, Sah R, Chandra R, Dhama K. COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes. J Pure Appl Microbiol 2020;14:1623-38. [DOI: 10.22207/jpam.14.3.01] [Cited by in Crossref: 13] [Article Influence: 6.5] [Reference Citation Analysis]
93 Nejadrahim R, Khademolhosseini S, Kavandi H, Hajizadeh R. Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report. J Med Case Rep 2021;15:143. [PMID: 33741059 DOI: 10.1186/s13256-021-02751-3] [Reference Citation Analysis]
94 Conte C, Esposito A, De Lorenzo R, Di Filippo L, Palmisano A, Vignale D, Leone R, Nicoletti V, Ruggeri A, Gallone G, Secchi A, Bosi E, Tresoldi M, Castagna A, Landoni G, Zangrillo A, De Cobelli F, Ciceri F, Camici P, Rovere-Querini P. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis 2021;31:2156-64. [PMID: 34059384 DOI: 10.1016/j.numecd.2021.04.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 McStay R, Johnstone A, Hare SS, Jacob J, Nair A, Rodrigues JCL, Edey A, Robinson G. COVID-19: looking beyond the peak. Challenges and tips for radiologists in follow-up of a novel patient cohort. Clin Radiol. 2021;76:74.e1-74.e14. [PMID: 33109350 DOI: 10.1016/j.crad.2020.09.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Raffaello WM, Huang I, Budi Siswanto B, Pranata R. In-depth review of cardiopulmonary support in COVID-19 patients with heart failure. World J Cardiol 2021; 13(8): 298-308 [PMID: 34589166 DOI: 10.4330/wjc.v13.i8.298] [Reference Citation Analysis]
97 Koh MCY, Li TYW, Ong JSY, Somani J, Ambhore AA. Stress Cardiomyopathy with Transient Biventricular Dysfunction Following Recent COVID-19 Infection. Acta Cardiol Sin 2021;37:204-7. [PMID: 33716463 DOI: 10.6515/ACS.202103_37(2).20201221A] [Reference Citation Analysis]
98 Zhu Z, Wang M, Lin W, Cai Q, Zhang L, Chen D, Liu F, Xiong X, Chu J, Peng J, Chen K. Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Immun Inflamm Dis 2021. [PMID: 34405950 DOI: 10.1002/iid3.471] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
99 Katkat F, Kalyoncuoğlu M, Karahan S, Abanus H, Turhan Çağlar FN, Karabulut D, Varol S, Şahin İ, Erkalp K, Okuyan E. Does coexistence of fragmented QRS and cardiovascular disease have the ability to predict the mortality in hospitalized, critically ill patients with COVID-19? Anatol J Cardiol 2021;25:803-10. [PMID: 34734814 DOI: 10.5152/AnatolJCardiol.2021.13611] [Reference Citation Analysis]
100 Chen X, Zheng L, Ye S, Xu M, Li Y, Lv K, Zhu H, Jie Y, Chen YQ. Research on Influencing Factors and Classification of Patients With Mild and Severe COVID-19 Symptoms. Front Cell Infect Microbiol 2021;11:670823. [PMID: 34490135 DOI: 10.3389/fcimb.2021.670823] [Reference Citation Analysis]
101 Soeiro AM, Pêgo-Fernandes PM. Post-COVID-19 cardiological alterations. Sao Paulo Med J 2021;139:543-4. [PMID: 34468629 DOI: 10.1590/1516-3180.2021.139628062021] [Reference Citation Analysis]
102 Zaninotto M, Mion MM, Padoan A, Babuin L, Plebani M. Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoring. Clin Chim Acta 2020;511:75-80. [PMID: 33010244 DOI: 10.1016/j.cca.2020.09.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
103 Duerr GD, Heine A, Hamiko M, Zimmer S, Luetkens JA, Nattermann J, Rieke G, Isaak A, Jehle J, Held SAE, Wasmuth JC, Wittmann M, Strassburg CP, Brossart P, Coburn M, Treede H, Nickenig G, Kurts C, Velten M. Parameters predicting COVID-19-induced myocardial injury and mortality. Life Sci 2020;260:118400. [PMID: 32918975 DOI: 10.1016/j.lfs.2020.118400] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
104 Mercedes BR, Serwat A, Naffaa L, Ramirez N, Khalid F, Steward SB, Feliz OGC, Kassab MB, Karout L. New-onset myocardial injury in pregnant patients with coronavirus disease 2019: a case series of 15 patients. Am J Obstet Gynecol 2021;224:387.e1-9. [PMID: 33098814 DOI: 10.1016/j.ajog.2020.10.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
105 Tanboğa IH, Canpolat U, Özcan Çetin EH, Kundi H, Turan S, Celik O, Ata N, Çay S, Özeke Ö, Kaymaz C, Topaloğlu S. The prognostic role of cardiac troponin in hospitalized COVID-19 patients. Atherosclerosis 2021;325:83-8. [PMID: 33910152 DOI: 10.1016/j.atherosclerosis.2021.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
106 Kelle S, Bucciarelli-Ducci C, Judd RM, Kwong RY, Simonetti O, Plein S, Raimondi F, Weinsaft JW, Wong TC, Carr J. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection.J Cardiovasc Magn Reson. 2020;22:61. [PMID: 32878639 DOI: 10.1186/s12968-020-00656-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
107 Meizinger C, Klugherz B. Focal ST-segment elevation without coronary occlusion: myocardial infarction with no obstructive coronary atherosclerosis associated with COVID-19-a case report. Eur Heart J Case Rep 2021;5:ytaa532. [PMID: 33768195 DOI: 10.1093/ehjcr/ytaa532] [Reference Citation Analysis]
108 Kini A, Cao D, Nardin M, Sartori S, Zhang Z, Pivato CA, Chiarito M, Nicolas J, Vengrenyuk Y, Krishnamoorthy P, Sharma SK, Dangas G, Fuster V, Mehran R. Types of myocardial injury and mid-term outcomes in patients with COVID-19. Eur Heart J Qual Care Clin Outcomes 2021;7:438-46. [PMID: 34458912 DOI: 10.1093/ehjqcco/qcab053] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Izquierdo A, Mojón D, Bardají A, Carrasquer A, Calvo-Fernández A, Carreras-Mora J, Giralt T, Pérez-Fernández S, Farré N, Soler C, Solà-Richarte C, Cabero P, Vaquerizo B, Marrugat J, Ribas N. Myocardial Injury as a Prognostic Factor in Mid- and Long-Term Follow-Up of COVID-19 Survivors. J Clin Med 2021;10:5900. [PMID: 34945196 DOI: 10.3390/jcm10245900] [Reference Citation Analysis]
110 Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc Med 2021;31:163-9. [PMID: 33383171 DOI: 10.1016/j.tcm.2020.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
111 Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, Johnston TP, Sahebkar A. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19:345-357. [PMID: 32921216 DOI: 10.1080/14787210.2020.1822737] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
112 Devarajan A, Vaseghi M. Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights. Redox Biol 2021;38:101810. [PMID: 33360293 DOI: 10.1016/j.redox.2020.101810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
113 Abate SM, Mantefardo B, Nega S, Chekole YA, Basu B, Ali SA, Taddesse M. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond) 2021;68:102594. [PMID: 34336202 DOI: 10.1016/j.amsu.2021.102594] [Reference Citation Analysis]
114 Julian DR, Kazakoff MA, Patel A, Jaynes J, Willis MS, Yates CC. Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19. Curr Pathobiol Rep 2021;:1-13. [PMID: 34900402 DOI: 10.1007/s40139-021-00226-0] [Reference Citation Analysis]
115 Carretta DM, Silva AM, D'Agostino D, Topi S, Lovero R, Charitos IA, Wegierska AE, Montagnani M, Santacroce L. Cardiac Involvement in COVID-19 Patients: A Contemporary Review. Infect Dis Rep 2021;13:494-517. [PMID: 34206074 DOI: 10.3390/idr13020048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Heaton HA, Luke A, Sztajnkrycer MD, Clements CM, De Moraes AG, Raukar NP. Best Practices in Managing Cardiac Arrest in the Emergency Department During the COVID-19 Pandemic. Mayo Clin Proc 2020;95:2704-8. [PMID: 33276842 DOI: 10.1016/j.mayocp.2020.10.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Khanduri A, Anand U, Doss M, Lovett L. Severe acute mitral valve regurgitation in a COVID-19-infected patient. BMJ Case Rep 2021;14:e239782. [PMID: 33462059 DOI: 10.1136/bcr-2020-239782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Schiavone M, Gasperetti A, Mancone M, Kaplan AV, Gobbi C, Mascioli G, Busana M, Saguner AM, Mitacchione G, Giacomelli A, Sardella G, Viecca M, Duru F, Antinori S, Carugo S, Bartorelli AL, Tondo C, Galli M, Fedele F, Forleo GB. Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease. J Clin Med 2020;9:E3263. [PMID: 33053826 DOI: 10.3390/jcm9103263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
119 Metkus TS, Sokoll LJ, Barth AS, Czarny MJ, Hays AG, Lowenstein CJ, Michos ED, Nolley EP, Post WS, Resar JR, Thiemann DR, Trost JC, Hasan RK. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome. Circulation 2021;143:553-65. [PMID: 33186055 DOI: 10.1161/CIRCULATIONAHA.120.050543] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
120 Mehan WA, Yoon BC, Lang M, Li MD, Rincon S, Buch K. Paraspinal Myositis in Patients with COVID-19 Infection. AJNR Am J Neuroradiol 2020;41:1949-52. [PMID: 32763902 DOI: 10.3174/ajnr.A6711] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
121 Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, Kulandhasamy M, Sesham K, Pareek V, Faiq MA, Pandey SN, Singh HN, Kant K, Shekhawat PS, Raza K, Kumar S. COVID-19 Mechanisms in the Human Body-What We Know So Far. Front Immunol 2021;12:693938. [PMID: 34790191 DOI: 10.3389/fimmu.2021.693938] [Reference Citation Analysis]
122 Metzl JD, McElheny K, Robinson JN, Scott DA, Sutton KM, Toresdahl BG. Considerations for Return to Exercise Following Mild-to-Moderate COVID-19 in the Recreational Athlete. HSS J 2020;:1-6. [PMID: 32837412 DOI: 10.1007/s11420-020-09777-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
123 Al Abbasi B, Torres P, Ramos-Tuarez F, Dewaswala N, Abdallah A, Chen K, Abdul Qader M, Job R, Aboulenain S, Dziadkowiec K, Bhopalwala H, Pino JE, Chait RD. Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality. Cardiol Res 2020;11:398-404. [PMID: 33224386 DOI: 10.14740/cr1159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
124 Hodges G, Pallisgaard J, Schjerning Olsen AM, McGettigan P, Andersen M, Krogager M, Kragholm K, Køber L, Gislason GH, Torp-Pedersen C, Bang CN. Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study. BMJ Open 2020;10:e041295. [PMID: 33268425 DOI: 10.1136/bmjopen-2020-041295] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
125 Assante R, D'Antonio A, Mannarino T, Gaudieri V, Zampella E, Mainolfi CG, Cantoni V, Green R, Caiazzo E, Nappi C, Criscuolo E, Bologna R, Zumbo G, Petretta M, Cuocolo A, Acampa W. Impact of COVID-19 infection on short-term outcome in patients referred to stress myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 2021. [PMID: 34773166 DOI: 10.1007/s00259-021-05619-2] [Reference Citation Analysis]
126 Stute NL, Stickford ASL, Stickford JL, Province VM, Augenreich MA, Bunsawat K, Alpenglow JK, Wray DW, Ratchford SM. Altered central and peripheral haemodynamics during rhythmic handgrip exercise in young adults with SARS-CoV-2. Exp Physiol 2021. [PMID: 34311498 DOI: 10.1113/EP089820] [Reference Citation Analysis]
127 Fath AR, Aglan A, Varkoly KS, Eldaly AS, Beladi RN, Forlemu A, Mihyawi N, Solsi A, Israr S, Lucas AR. Distinct Coagulopathy With Myocardial Injury and Pulmonary Embolism in COVID-19. J Investig Med High Impact Case Rep 2021;9:23247096211019559. [PMID: 34036814 DOI: 10.1177/23247096211019559] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Al-Wahaibi K, Al-Wahshi Y, Mohamed Elfadil O. Myocardial Injury Is Associated with Higher Morbidity and Mortality in Patients with 2019 Novel Coronavirus Disease (COVID-19). SN Compr Clin Med 2020;:1-7. [PMID: 33052322 DOI: 10.1007/s42399-020-00569-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
129 Hoepler W, Traugott MT, Christ G, Kitzberger R, Pawelka E, Karolyi M, Seitz T, Baumgartner S, Kelani H, Wenisch C, Laferl H, Zoufaly A, Weseslindtner L, Neuhold S. Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report. SN Compr Clin Med 2021;:1-6. [PMID: 33426474 DOI: 10.1007/s42399-020-00683-5] [Reference Citation Analysis]
130 Sisakian H, Martirosyan S, Shekoyan S, Terteryan A, Hovhannisyan M. Asymptomatic COVID-19 and ST-elevation myocardial infarction in young adults: lessons learned from two similar cases. ESC Heart Fail 2021. [PMID: 34779152 DOI: 10.1002/ehf2.13690] [Reference Citation Analysis]
131 Sanchez BG, Gasalla JM, Sánchez-Chapado M, Bort A, Diaz-Laviada I. Increase in Ischemia-Modified Albumin and Pregnancy-Associated Plasma Protein-A in COVID-19 Patients. J Clin Med 2021;10:5474. [PMID: 34884175 DOI: 10.3390/jcm10235474] [Reference Citation Analysis]
132 Sonsoz MR, Alp ME, Guven G, Guler A, Unsel M, Altuntas Aydin O. Increasing modified CHA2DS2-VASc risk score is associated with acute cardiac injury in hospitalised COVID-19 patients. Acta Cardiol 2021;:1-7. [PMID: 34275416 DOI: 10.1080/00015385.2021.1952000] [Reference Citation Analysis]
133 Sonsoz MR, Oncul A, Cevik E, Orta H, Yilmaz M, Ayduk Govdeli E, Nalbant A, Demirtakan ZG, Tonyali M, Durmus D, Anakli I, Polat O, Catma Y, Senkal N, Medetalibeyoglu A, Kose M, Emet S, Tukek T. Wide QRS Complex and Lateral ST-T Segment Abnormality Are Associated With Worse Clinical Outcomes in COVID-19 Patients. Am J Med Sci 2021;361:591-7. [PMID: 33581838 DOI: 10.1016/j.amjms.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
134 Lozahic C, Maddock H, Sandhu H. Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19. Front Cardiovasc Med 2021;8:634291. [PMID: 33969006 DOI: 10.3389/fcvm.2021.634291] [Reference Citation Analysis]
135 John KJ, Nayar J, Mishra AK, Selvaraj V, Khan MS, Lal A. In-hospital clinical complications of COVID-19: a brief overview. Future Virol 2021. [PMID: 34777553 DOI: 10.2217/fvl-2021-0200] [Reference Citation Analysis]
136 Paul RW, Omari A, Fliegel B, Bishop ME, Erickson BJ, Alberta FG. Effect of COVID-19 on Ulnar Collateral Ligament Reconstruction in Major League Baseball Pitchers. Orthop J Sports Med 2021;9:23259671211041359. [PMID: 34497864 DOI: 10.1177/23259671211041359] [Reference Citation Analysis]
137 Banerjee Y, Pantea Stoian A, Silva-Nunes J, Sonmez A, Rizvi AA, Janez A, Rizzo M. The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism. Expert Opin Drug Saf 2021;20:1309-15. [PMID: 34424130 DOI: 10.1080/14740338.2021.1970744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Jakhmola S, Indari O, Kashyap D, Varshney N, Rani A, Sonkar C, Baral B, Chatterjee S, Das A, Kumar R, Jha HC. Recent updates on COVID-19: A holistic review. Heliyon 2020;6:e05706. [PMID: 33324769 DOI: 10.1016/j.heliyon.2020.e05706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
139 Gulletta S, Della Bella P, Pannone L, Falasconi G, Cianfanelli L, Altizio S, Cinel E, Da Prat V, Napolano A, D'Angelo G, Brugliera L, Agricola E, Landoni G, Tresoldi M, Rovere PQ, Ciceri F, Zangrillo A, Vergara P. QTc interval prolongation, inflammation, and mortality in patients with COVID-19. J Interv Card Electrophysiol 2021. [PMID: 34291390 DOI: 10.1007/s10840-021-01033-8] [Reference Citation Analysis]
140 Jafari-oori M, Dehi M, Ebadi A, Moradian ST, jafari M. Incidence of cardiac complications following COVID-19 infection: An umbrella meta-analysis study. Heart & Lung 2022. [DOI: 10.1016/j.hrtlng.2022.01.001] [Reference Citation Analysis]
141 Paone G. Commentary: Cause for concern or 1 in 33 million? JTCVS Tech 2020;4:114-5. [PMID: 33111130 DOI: 10.1016/j.xjtc.2020.10.033] [Reference Citation Analysis]
142 Parra-Lucares A, Toro L, Weitz-Muñoz S, Ramos C. Cardiomyopathy Associated with Anti-SARS-CoV-2 Vaccination: What Do We Know? Viruses 2021;13:2493. [PMID: 34960761 DOI: 10.3390/v13122493] [Reference Citation Analysis]